Coliprotec News
UK diagnostic testing data has indicated that vaccinating with Coliprotec to prevent post-weaning diarrhoea (PWD) in piglets, could be an effective strategy in nearly 60 percent of herds.
In-water vaccination is still regarded as quite a novel technique in pig production. However, more producers are considering how medicines delivered through drinking water could save them time and money.
E. Coli post-weaning diarrhoea (PWD) is a common issue across farms worldwide and the means for treating it and preventing it are at odds amongst the industry.
More Materials
Coliprotec F4/F18 is an oral vaccine used for active immunization of pigs from 18 days of age against enterotoxigenic F4-positive and F18-positive Escherichia coli in order to reduce the incidence of moderate to severe post-weaning diarrhoea infected pigs and reduce the faecal shedding of enterotoxigenic F4-positive and F18-positive E. coli from infected pigs.
Each dose of vaccine contains 1.3 x 108 to 9.0 x 108 CFU of live non-pathogenic Escherichia coli O8:K87 (F4ac) and 2.8 x 108 to 3.0 x 109 CFU of live non-pathogenic Escherichia coli O141:K94 (F18ac). Refer to the product packaging and leaflets for information about side effects, precautions, warnings and contraindications. Legal category POM-V. Advice should be sought from the Medicine Prescriber. For further information consult the product SPC. Prescription decisions are for the person issuing the prescription alone.
Coliprotec, Elanco™ and the diagonal bar are trademarks of Elanco or its affiliates.
